FUNCTIONAL-CHARACTERIZATION OF A MUTATED CHICKEN ALPHA(7) NICOTINIC ACETYLCHOLINE-RECEPTOR SUBUNIT WITH A LEUCINE RESIDUE INSERTED IN TRANSMEMBRANE DOMAIN-2
Sd. Buckingham et al., FUNCTIONAL-CHARACTERIZATION OF A MUTATED CHICKEN ALPHA(7) NICOTINIC ACETYLCHOLINE-RECEPTOR SUBUNIT WITH A LEUCINE RESIDUE INSERTED IN TRANSMEMBRANE DOMAIN-2, British Journal of Pharmacology, 124(4), 1998, pp. 747-755
1 Site-directed mutagenesis was used to create an altered form of the
chicken a, nicotinic acetylcholine (ACh) receptor subunit (alpha(7)x61
) in which a leucine residue was inserted between residues Leu9' and S
er10' in transmembrane domain . The properties of a(7)x61 receptors ar
e distinct from those of the wild-type receptor. 2 Oocytes expressing
wild-type alpha(7) receptors responded to 10 mu M nicotine with rapid
inward currents that desensitized with a time-constant of 710 +/- 409
ms (mean +/- s.e.mean, n = 5). However in alpha(7)x61 receptors 10 mu
M nicotine resulted in slower onset inward currents that desensitized
with a time-constant of 5684 +/- 3403 ms (mean +/- s.e.mean, n = 4). N
o significant difference in the apparent affinity of nicotine or acety
lcholine between mutant and wild-type receptors was observed. Dihydro-
beta-erythroidine (DK beta E) acted as an antagonist on both receptors
. 3 Molecular modelling of the alpha(7)x61 receptor channel pore forme
d by a bundle of M2 alpha-helices suggested that three of the channel
lining residues would be altered by the leucine insertion i.e.; Ser10'
would be replaced by the leucine insertion, Val13' and Phe14' would b
e replaced, by Thr and Val, respectively. 4 When present in the LEV-1
nicotinic ACh receptor subunit from Caenorhabditis elegans the same al
teration conferred resistance to levamisole anthelmintic drug. Levamis
ole blocked responses to nicotine of wild-type and alpha(7)x61 recepto
rs. However, block was more dependent on membrane potential for the al
pha(7)x61 receptors. 5 We conclude that the leucine insertion in trans
membrane domain 2 has the unusual effect of slowing desensitization wi
thout altering apparent agonist affinity.